BIO-key International (BKYI) Set to Post Earnings on Friday

BIO-key International (NASDAQ:BKYI – Get Free Report) is projected to post its Q3 2026 resultson Friday, November 13th. Analysts expect the company to post earnings of ($0.35) per share and revenue of $2.40 million for the quarter. Individuals may review the information on the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Friday, November 13, 2026 at 10:00 AM ET.

BIO-key International (NASDAQ:BKYI – Get Free Report) last posted its earnings results on Thursday, August 13th. The technology company reported ($0.56) EPS for the quarter, topping the consensus estimate of ($0.82) by $0.26. The company had revenue of $1.92 million during the quarter, compared to the consensus estimate of $1.80 million. BIO-key International had a negative net margin of 50.01% and a negative return on equity of 67.31%. On average, analysts expect BIO-key International to post ($1.62) EPS for the current fiscal year and $0.22 EPS for the next fiscal year.

BIO-key International Stock Performance

BIO-key International stock opened at $2.37 on Friday. BIO-key International has a 1-year low of $1.55 and a 1-year high of $13.80. The firm’s fifty day simple moving average is $2.53 and its 200-day simple moving average is $4.50.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Zacks Research raised BIO-key International to a “hold” rating in a report on Thursday, August 6th. Wall Street Zen raised BIO-key International to a “hold” rating in a research report on Saturday, October 24th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of BIO-key International in a report on Thursday, October 15th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, BIO-key International has an average rating of “Reduce”.

Get Our Latest Report on BIO-key International

About BIO-key International

(Get Free Report)

BIO-key International, Inc (NASDAQ: BKYI) develops biometric authentication and identity and access management solutions. The company helps organizations secure access to applications, networks, devices and data through fingerprint recognition and other authentication methods designed to reduce reliance on passwords.

Its product portfolio includes PortalGuard, an identity and access management platform that supports single sign-on, multifactor authentication, self-service password management and access control.

See Also

Earnings History for BIO-key International (NASDAQ:BKYI)

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.